Japan's orphan drug market — explained

WEDNESDAY, NOVEMBER 19, 2025 |  11:00 AM - 1:00 PM ET

The opportunity in Japan’s rare disease market is substantial, yet drug developers need both regulatory know-how and strategic positioning to succeed. This exclusive virtual event connects you directly with PMDA officials who oversee orphan drug designations and industry leaders currently navigating these pathways.

Learn from biotechs already operating in Japan about market entry strategies, partnership opportunities, and how to maximize your rare disease portfolio’s potential.

Whether you’re exploring new territories or fine-tuning your Japan entry strategy, this session delivers the guidance you need to make your next move count. Join us.